Zaloguj się

Gotowe bibliografie tematyczne / Glycogen storage disease type III / Artykuły w czasopismach

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Glycogen storage disease type III.

Artykuły w czasopismach na temat „Glycogen storage disease type III”

Autor: Grafiati

Data publikacji: 14 grudnia 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Glycogen storage disease type III”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Carvalho, Julene S., Eurem E. Matthews, James V. Leonard, and John Deanfield. "Cardiomyopathy of glycogen storage disease type III." Heart and Vessels 8, no. 3 (1993): 155–59. http://dx.doi.org/10.1007/bf01744800.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Labrune, Philippe, Pascale Trioche, Isabelle Duvaltier, Paquita Chevalier, and Michel Odièvre. "Hepatocellular Adenomas in Glycogen Storage Disease Type I and III: A Series of 43 Patients and Review of the Literature." Journal of Pediatric Gastroenterology and Nutrition 24, no. 3 (1997): 276–79. http://dx.doi.org/10.1002/j.1536-4801.1997.tb00424.x.

Pełny tekst źródła

Streszczenie:

Background:Hepatocellular adenomas may develop in patients with glycogen storage disease types I and III, and the malignant degeneration of adenomas in hepatocellular carcinoma has been reported in ten cases. The aim of this work was to study the characteristics of hepatic adenomas in a large series of 43 patients with glycogen storage disease types I and III and to determine the optimal means of follow‐up.Methods:The charts of 43 patients with glycogen storage disease type I and III were studied. In all these patients, abdominal ultrasonography and the determination of serum α‐fetoprotein had

Style APA, Harvard, Vancouver, ISO itp.

3

Shen, J., and Y. Chen. "Molecular Characterization of Glycogen Storage Disease Type III." Current Molecular Medicine 2, no. 2 (2002): 167–75. http://dx.doi.org/10.2174/1566524024605752.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Minen, Federico, Gabriele Cont, Angela De Cunto, et al. "Delayed Diagnosis of Glycogen Storage Disease Type III." Journal of Pediatric Gastroenterology and Nutrition 54, no. 1 (2012): 122–24. http://dx.doi.org/10.1097/mpg.0b013e318228d806.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Cleary, M. A., J. H. Walter, B. A. Kerr, and J. E. Wraith. "Facial appearance in glycogen storage disease type III." Clinical Dysmorphology 11, no. 2 (2002): 117–20. http://dx.doi.org/10.1097/00019605-200204000-00008.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

MOSES, S. W., N. GADOTH, N. BASHAN, E. BEN-DAVID, A. SLONIM, and K. L. WANDERMAN. "Neuromuscular Involvement in Glycogen Storage Disease Type III." Acta Paediatrica 75, no. 2 (1986): 289–96. http://dx.doi.org/10.1111/j.1651-2227.1986.tb10201.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Korlimarla, Aditi, Stephanie Austin, Baodong Sun, and Priya Kishnani. "Hepatic Manifestations in Glycogen Storage Disease Type III." Current Pathobiology Reports 6, no. 4 (2018): 233–40. http://dx.doi.org/10.1007/s40139-018-0182-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Liu, Kai-Ming, Jer-Yuarn Wu, and Yuan-Tsong Chen. "Mouse model of glycogen storage disease type III." Molecular Genetics and Metabolism 111, no. 4 (2014): 467–76. http://dx.doi.org/10.1016/j.ymgme.2014.02.005.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Salemi, Vera Maria Cury, Léa Maria Macruz Ferreira Demarchi, Estêvan Vieira Cabeda, Jaqueline Wagenführ, and Ana Cristina Tanaka. "Type III glycogen storage disease mimicking hypertrophic cardiomyopathy." European Heart Journal - Cardiovascular Imaging 13, no. 2 (2011): 197. http://dx.doi.org/10.1093/ejechocard/jer231.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Zimakas, P. J. A. "Glycogen storage disease type III in Inuit children." Canadian Medical Association Journal 172, no. 3 (2005): 355–58. http://dx.doi.org/10.1503/cmaj.1031589.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Moses, S. W., K. L. Wanderman, A. Myroz, and M. Frydman. "Cardiac involvement in glycogen storage disease type III." European Journal of Pediatrics 148, no. 8 (1989): 764–66. http://dx.doi.org/10.1007/bf00443106.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Labrune, Ph, C. Benattar, N. Ammoury, J. Chalas, A. Lindenbaum та M. Odièvre. "Serum Concentrations of Albumin, C‐Reactive Protein, α₂‐Macroglobulin, Prealbumin, Fibronectin, Fibrinogen, Transferrin, and Retinol Binding Protein in 55 Patients with Hepatic Glycogen Storage Diseases". Journal of Pediatric Gastroenterology and Nutrition 18, № 1 (1994): 41–44. http://dx.doi.org/10.1002/j.1536-4801.1994.tb11120.x.

Pełny tekst źródła

Streszczenie:

Summary:Hepatic glycogen storage diseases are hereditary metabolic disorders involving the metabolism of glycogen. This study was designed to investigate the serum protein status in such diseases. Fifty‐five patients with glycogen storage disease types I, III, VI, and IX, whose ages ranged from 1 month to 27 years, were included in this work. C‐reactive protein, fibrinogen, α2‐macroglobulin, albumin, transferrin, fibronectin, retinol binding protein, and prealbumin serum concentrations were measured in each patient. In patients affected with type I glycogen storage disease, serum concentration

Style APA, Harvard, Vancouver, ISO itp.

13

Gharpure, Varsha, Kalyani Raghavan, Meenakshi Mehta, and Alka Kalgutkar. "Glycogen storage disease type IIa." Indian Journal of Pediatrics 63, no. 2 (1996): 259–62. http://dx.doi.org/10.1007/bf02845254.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Fayssoil, Abdallah, Pascal Laforet, Vincent Gajdos, et al. "0224: Cardiac involvement in glycogen storage disease type III." Archives of Cardiovascular Diseases Supplements 8, no. 1 (2016): 35. http://dx.doi.org/10.1016/s1878-6480(16)30109-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Oki, Y., M. Okubo, S. Tanaka, K. Nakanishi, T. Kobayashi, and T. Murase. "Diabetes mellitus secondary to glycogen storage disease type III." Diabetic Medicine 17, no. 11 (2000): 810–12. http://dx.doi.org/10.1046/j.1464-5491.2000.00378.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Haller, R. G. "Glycogen storage disease type III: The phenotype branches out." Neurology 84, no. 17 (2015): 1726–27. http://dx.doi.org/10.1212/wnl.0000000000001532.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Galvin-Parton, P., and F. A. Hommes. "Abnormal oligosaccharide pattern in glycogen storage disease type III." Journal of Inherited Metabolic Disease 19, no. 3 (1996): 383–84. http://dx.doi.org/10.1007/bf01799279.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Tada, Hiroshi, Takashi Kurita, Tohru Ohe, et al. "Glycogen storage disease type III associated with ventricular tachycardia." American Heart Journal 130, no. 4 (1995): 911–12. http://dx.doi.org/10.1016/0002-8703(95)90097-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Hobson-Webb, Lisa D., Stephanie L. Austin, Deeksha S. Bali, and Priya S. Kishnani. "The electrodiagnostic characteristics of Glycogen Storage Disease Type III." Genetics in Medicine 12, no. 7 (2010): 440–45. http://dx.doi.org/10.1097/gim.0b013e3181cd735b.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Kishnani, Priya S., Stephanie L. Austin, Pamela Arn, et al. "Glycogen Storage Disease Type III diagnosis and management guidelines." Genetics in Medicine 12, no. 7 (2010): 446–63. http://dx.doi.org/10.1097/gim.0b013e3181e655b6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Crushell, Ellen, Eileen P. Treacy, J. Dawe, M. Durkie, and Nicholas J. Beauchamp. "Glycogen storage disease type III in the Irish population." Journal of Inherited Metabolic Disease 33, S3 (2010): 215–18. http://dx.doi.org/10.1007/s10545-010-9096-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Spengos, Konstantinos, Helen Michelakakis, Adamantios Vontzalidis, Vasiliki Zouvelou, and Panagiota Manta. "Diabetes mellitus associated with glycogen storage disease type III." Muscle & Nerve 39, no. 6 (2009): 876–77. http://dx.doi.org/10.1002/mus.21201.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Burlina, A. B., S. Piovan, L. Grazian, and F. Zacchello. "MULTIPLE SCLEROSIS IN GLYCOGEN STORAGE DISEASE TYPE III (GSD-III). 842." Pediatric Research 39 (April 1996): 143. http://dx.doi.org/10.1203/00006450-199604001-00864.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Borowitz, Stephen M., and Harry L. Greene. "Cornstarch Therapy in a Patient with Type III Glycogen Storage Disease." Journal of Pediatric Gastroenterology and Nutrition 6, no. 4 (1987): 631–34. http://dx.doi.org/10.1002/j.1536-4801.1987.tb09364.x.

Pełny tekst źródła

Streszczenie:

SummaryA child with type III glycogen storage disease is described. The patient presented with growth failure and hepatic dysfunction, and no clinical or biochemical evidence of myopathy. Institution of high protein nocturnal intragastric feedings was associated with improved growth and less hepatic dysfunction. Compliance with tube feedings was sporadic necessitating another approach to the patient's management. The use of oral cornstarch supplements enabled the child to maintain normoglycemia and was associated with clinical and biochemical improvement. Our experience with this child suggest

Style APA, Harvard, Vancouver, ISO itp.

25

Karwowski, Christine, Csaba Galambos, David Finegold, and Benjamin L. Shneider. "Markedly Elevated Serum Transaminases in Glycogen Storage Disease Type III." Journal of Pediatric Gastroenterology and Nutrition 52, no. 5 (2011): 621–23. http://dx.doi.org/10.1097/mpg.0b013e31820e6a55.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Gremse, D. A., J. C. Bucuvalas, and W. F. Balistreri. "Efficacy of cornstarch therapy in type III glycogen-storage disease." American Journal of Clinical Nutrition 52, no. 4 (1990): 671–74. http://dx.doi.org/10.1093/ajcn/52.4.671.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Maire, I., G. Mandon, and M. Mathieu. "First Trimester Prenatal Diagnosis of Glycogen Storage Disease Type III." Journal of Inherited Metabolic Disease 12, S2 (1989): 292–94. http://dx.doi.org/10.1007/bf03335402.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Shin, Y. S., M. Rieth, J. Tausenfreund, and W. Endres. "First Trimester Diagnosis of Glycogen Storage Disease Type II and Type III." Journal of Inherited Metabolic Disease 12, S2 (1989): 289–91. http://dx.doi.org/10.1007/bf03335401.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Seol, Jaehee, Seyong Jung, Hong Koh, Jowon Jung, and Yunkoo Kang. "Echocardiographic Assessment of Patients with Glycogen Storage Disease in a Single Center." International Journal of Environmental Research and Public Health 20, no. 3 (2023): 2191. http://dx.doi.org/10.3390/ijerph20032191.

Pełny tekst źródła

Streszczenie:

Glycogen storage disease (GSD) is a hereditary metabolic disorder caused by enzyme deficiency resulting in glycogen accumulation in the liver, muscle, heart, or kidney. GSD types II, III, IV, and IX are associated with cardiac involvement. However, cardiac manifestation in other GSD types is unclear. This study aimed to describe whether energy deprivation and the toxic effects of accumulated glycogen affect the heart of patients with GSD. We evaluated the left ventricle (LV) wall mass, LV systolic and diastolic function and myocardial strain with conventional echocardiography and two-dimension

Style APA, Harvard, Vancouver, ISO itp.

30

Ondruskova, Nina, Tomas Honzik, Hana Kolarova, et al. "Aberrant apolipoprotein C-III glycosylation in glycogen storage disease type III and IX." Metabolism 82 (May 2018): 135–41. http://dx.doi.org/10.1016/j.metabol.2018.01.004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Borowitz, Stephen M., and Harry L. Greene. "Cornstarch Therapy in a Patient with Type III Glycogen Storage Disease." Journal of Pediatric Gastroenterology and Nutrition 6, no. 4 (1987): 631–34. http://dx.doi.org/10.1097/00005176-198707000-00024.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Kaji, M. "A case of Costello syndrome and glycogen storage disease type III." Journal of Medical Genetics 39, no. 2 (2002): 8e—8. http://dx.doi.org/10.1136/jmg.39.2.e8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Labrune, Philippe. "Absence of specific facial dysmorphy in glycogen storage disease type III." Clinical Dysmorphology 12, no. 3 (2003): 213. http://dx.doi.org/10.1097/00019605-200307000-00017.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

BHATTI, Shazia, and Emma PARRY. "Successful pregnancy in a woman with glycogen storage disease type III." Australian and New Zealand Journal of Obstetrics and Gynaecology 46, no. 2 (2006): 168–69. http://dx.doi.org/10.1111/j.1479-828x.2006.00549.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Hershkovitz, E., A. Donald, M. Mullen, P. J. Lee, and J. V. Leonard. "Blood lipids and endothelial function in glycogen storage disease type III." Journal of Inherited Metabolic Disease 22, no. 8 (1999): 891–98. http://dx.doi.org/10.1023/a:1005687323096.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Lee, P., M. Burch, and J. V. Leonard. "Plasma creatine kinase and cardiomyopathy in glycogen storage disease type III." Journal of Inherited Metabolic Disease 18, no. 6 (1995): 751–52. http://dx.doi.org/10.1007/bf02436768.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Labrune, Philippe. "Absence of specific facial dysmorphy in glycogen storage disease type III." Clinical Dysmorphology 12, no. 3 (2003): 213. http://dx.doi.org/10.1097/01.mcd.0000052342.43310.35.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Pagliarani, Serena, Sabrina Lucchiari, Gianna Ulzi, et al. "Glycogen storage disease type III: A novel Agl knockout mouse model." Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1842, no. 11 (2014): 2318–28. http://dx.doi.org/10.1016/j.bbadis.2014.07.029.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Demo, Erin, Donald Frush, Marcia Gottfried, et al. "Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?" Journal of Hepatology 46, no. 3 (2007): 492–98. http://dx.doi.org/10.1016/j.jhep.2006.09.022.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Herlin, Bastien, Pascal Laforět, Philippe Labrune, Emmanuel Fournier, and Tanya Stojkovic. "Peripheral neuropathy in glycogen storage disease type III: Fact or myth?" Muscle & Nerve 53, no. 2 (2015): 310–12. http://dx.doi.org/10.1002/mus.24977.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Ding, Jia-Huan, T. de Barsy, Barbara I. Brown, Rosalind A. Coleman, and Yuan-Tsong Chen. "Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III." Journal of Pediatrics 116, no. 1 (1990): 95–100. http://dx.doi.org/10.1016/s0022-3476(05)81652-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Kishnani, Priya S., Baodong Sun, and Dwight D. Koeberl. "Gene therapy for glycogen storage diseases." Human Molecular Genetics 28, R1 (2019): R31—R41. http://dx.doi.org/10.1093/hmg/ddz133.

Pełny tekst źródła

Streszczenie:

AbstractThe focus of this review is the development of gene therapy for glycogen storage diseases (GSDs). GSD results from the deficiency of specific enzymes involved in the storage and retrieval of glucose in the body. Broadly, GSDs can be divided into types that affect liver or muscle or both tissues. For example, glucose-6-phosphatase (G6Pase) deficiency in GSD type Ia (GSD Ia) affects primarily the liver and kidney, while acid α-glucosidase (GAA) deficiency in GSD II causes primarily muscle disease. The lack of specific therapy for the GSDs has driven efforts to develop new therapies for t

Style APA, Harvard, Vancouver, ISO itp.

43

Artan, R., O. P. van Diggelen, and J. G. M. Huijmans. "Glycogen storage disease type III with diagnosis complicated by gluten-sensitive enteropathy." Journal of Inherited Metabolic Disease 21, no. 4 (1998): 437–38. http://dx.doi.org/10.1023/a:1005331414257.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Preisler, Nicolai, Agnès Pradel, Edith Husu, et al. "Exercise intolerance in Glycogen Storage Disease Type III: Weakness or energy deficiency?" Molecular Genetics and Metabolism 109, no. 1 (2013): 14–20. http://dx.doi.org/10.1016/j.ymgme.2013.02.008.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Mishori-Dery, A., N. Bashan, S. Moses, et al. "RFLPs for linkage analysis in families with glycogen storage disease type III." Journal of Inherited Metabolic Disease 18, no. 2 (1995): 207–10. http://dx.doi.org/10.1007/bf00711768.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Larizza, D., G. Maggiore, D. Marzani, M. Maghnie, and R. Ciceri. "Difficult hGH treatment in a patient with type III glycogen storage disease." European Journal of Pediatrics 145, no. 1-2 (1986): 84–85. http://dx.doi.org/10.1007/bf00441862.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Derks, Terry G. J., and G. Peter A. Smit. "Dietary management in glycogen storage disease type III: what is the evidence?" Journal of Inherited Metabolic Disease 38, no. 3 (2014): 545–50. http://dx.doi.org/10.1007/s10545-014-9756-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Sentner, Christiaan P., Irene J. Hoogeveen, David A. Weinstein, et al. "Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome." Journal of Inherited Metabolic Disease 39, no. 5 (2016): 697–704. http://dx.doi.org/10.1007/s10545-016-9932-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Anwar, Sayeeda, AKM Matiur Rahaman, Abdul Matin, Dipa Saha, and Maliha Rashid. "Glycogen Storage Disease Type III-Coris Disease: A Case Report and Review Literature." Bangladesh Journal of Child Health 39, no. 3 (2017): 161–63. http://dx.doi.org/10.3329/bjch.v39i3.31584.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Jahun, Mahmud Gambo, and Umar Isa Umar. "Glycogen Storage Disease Type III Presenting as Recurrent Seizure Disorder in a Second Twin: A Case Report." Bayero Journal of Nursing and Health Care 5, no. 1 (2023): 1185–90. http://dx.doi.org/10.4314/bjnhc.v5i1.8.

Pełny tekst źródła

Streszczenie:

Glycogen storage diseases (GSDs) are a group of genetic autosomal recessive metabolic disorders resulting from deficiencies of enzymes of glycogen metabolism occurring in the liver, muscles or kidneys. Various types and sub-types exist based on genetic classification presenting with symptoms and signs of hypoglycaemia, hepatomegaly and myopathy depending on severity, and age of onset. A high index of suspicion is required for the diagnosis of GSDs. An eighteen-month-old girl who was apparently healthy with normal development was without any abnormality until about 12 months of age when she had

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!